Abstract
The revolution in DNA technology has permitted the development of otherwise unavailable and novel biological medicines; has provided new and efficient methods for the large-scale production of existing substances; is the basis for novel, highly sensitive and specific diagnostic tests; has developed new techniques in genetic engineering; is the basis for the development of new and safer vaccines, which are more effective and can be produced in larger quantities than by any other means; is a major key to new fundamental understanding of normal and disease processes.
As far as risks are concerned, a few examples will be mentioned, related to biotechnology-derived products (biologicals), human embryonic stem cells, gene therapy and application of functional genomics. As a final step, the so-called precautionary principle will be introduced, since it raises a cluster of questions about how prudently to engage in risk-taking.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Ebbesen, M., & Jensen, T. G. (2006). Nanomedicine: Techniques, potentials, and ethical implications. Journal of Biomedicine and Biotechnology, 5, 515–516.
Habermas, J. (2003). The future of human nature. Cambridge: Polity.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science + Business Media B.V
About this chapter
Cite this chapter
Bosìa, A. (2008). Health Risks and Benefits from Biotechnology. In: Molfino, F., Zucco, F. (eds) Women in Biotechnology. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-8611-3_18
Download citation
DOI: https://doi.org/10.1007/978-1-4020-8611-3_18
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-8610-6
Online ISBN: 978-1-4020-8611-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)